Lungenmetastasen – Onkologische Bedeutung und Therapie

Köhler D, Schönhofer B, Voshaar T (2010) Pneumologie. Thieme, Stuttgart, S 241 ISBN 978-3-13-146281‑7. Suster S, Moran C (2013) Metastatic tumors to the lung. In: Biopsy interpretation of the Lung. Wolters Kluwer, S 369–401. ISBN 978-0-7817-8467‑2 Suster S, Moran C (2012) Neoplasms, metastatic. In: Diagnostic pathology, thoracic. Amirsys, S I‑3-2–I-3-33. ISBN 978-1-931884-49‑5 Vliegenthart R, Fouras A, Jacobs C, Papanikolaou N (2022) Innovations in thoracic imaging: CT, radiomics, AI and x‑ray velocimetry. Respirology 27(10):818–833. https://doi.org/10.1111/resp.14344 Brandman S, Ko JP (2011) Pulmonary nodule detection, characterization, and management with multidetector computed tomography. J Thorac Imaging 26(2):90–105 Vogl TJ, Eckert R, Naguib NN, Beeres M, Gruber-Rouh T, Nour-Eldin NA (2016) Thermal ablation of colorectal lung metastases: retrospective comparison among laser-induced thermotherapy, radiofrequency ablation, and microwave ablation. AJR Am J Roentgenol 207(6):1340–1349 Hirsch FW, Sorge I, Vogel-Claussen J, Roth C, Gräfe D, Päts A, Voskrebenzev A, Anders RM (2020) The current status and further prospects for lung magnetic resonance imaging in pediatric radiology. Pediatr Radiol 50(5):734–749 Jurmeister P, Schöler A, Arnold A, Klauschen F, Lenze D, Hummel M, Schweizer L, Bläker H, Pfitzner BM, Mamlouk S, Sers C, Denkert C, Stichel D, Frost N, Horst D, von Laffert M, Capper D (2019) DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Mod Pathol 32(6):855–865 Jurmeister P, Vollbrecht C, Behnke A, Frost N, Arnold A, Treue D, Rückert JC, Neudecker J, Schweizer L, Klauschen F, Horst D, Hummel M, Dietel M, von Laffert M (2019) Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options. Lung Cancer 138:43–51 Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S, ESMO Guidelines Committee (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv1–iv21 Murakawa T (2021) Past, present, and future perspectives of pulmonary metastasectomy for patients with advanced colorectal cancer. Surg Today 51(2):204–211 Okumura T, Boku N, Hishida T, Ohde Y, Sakao Y, Yoshiya K, Higashiyama M, Hyodo I, Mori K, Kondo H (2017) Surgical outcome and prognostic stratification for pulmonary metastasis from colorectal cancer. Ann Thorac Surg 104(3):979–987 Meacci E, Nachira D, Congedo MT, Porziella V, Chiappetta M, Ferretti G, Iaffaldano A, Ciavarella LP, Margaritora S (2017) Lung metastasectomy following kidney tumors: outcomes and prognostic factors from a single-center experience. J Thorac Dis 9(Suppl 12):S1267–S1272 Marulli G, Mammana M, Comacchio G, Rea F (2017) Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis 9(Suppl 12):S1305–S1315 Shiono S (2021) The role of pulmonary metastasectomy for pulmonary metastasis from head and neck cancer. J Thorac Dis 13(4):2643–2648 Girelli L, Locati L, Galeone C, Scanagatta P, Duranti L, Licitra L, Pastorino U (2017) Lung metastasectomy in adenoid cystic cancer: Is it worth it? Oral Oncol 65:114–118 Kanzaki R, Fukui E, Kanou T, Ose N, Funaki S, Minami M, Shintani Y, Okumura M (2021) Preoperative evaluation and indications for pulmonary metastasectomy. J Thorac Dis 13(4):2590–2602 Schlachtenberger G, Doerr F, Menghesha H, Lauinger P, Wolber P, Sabashnikov A, Popov AF, Macherey-Meyer S, Bennink G, Klussmann JP, Wahlers T, Hekmat K, Heldwein MB (2022) Patients with pulmonary metastases from head and neck cancer benefit from pulmonary metastasectomy, a systematic review. Medicina 58(8):1000 Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, Johnston M, McCormack P, Pass H, Putnam JB Jr (1997) International registry of lung metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113(1):37–49 Bong CY, Smithers BM, Chua TC (2021) Pulmonary metastasectomy in the era of targeted therapy and immunotherapy. J Thorac Dis 13(4):2618–2627 Handy JR, Bremner RM, Crocenzi TS, Detterbeck FC, Fernando HC, Fidias PM, Firestone S, Johnstone CA, Lanuti M, Litle VR, Kesler KA, Mitchell JD, Pass HI, Ross HJ, Varghese TK (2019) Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg 107(2):631–649 Gonzalez M, Brunelli A, Szanto Z, Passani S, Falcoz PE (2021) Report from the European society of thoracic surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy. Eur J Cardiothorac Surg 59(5):996–1003 Panagiotopoulos N, Patrini D, Lawrence D, Scarci M, Mitsos S (2018) Pulmonary metastasectomy and laser-assisted resection. J Thorac Dis 10(Suppl 17):S1930–S1933. https://doi.org/10.21037/jtd.2018.05.08 Rusidanmu A, Chin W, Xu J, Wang L, He Z, Lv X, Hu J (2021) Does a thoracoscopic approach provide better outcomes for pulmonary metastases? J Thorac Dis 13(4):2692–2697 Adebahr S, Hechtner M, Schräder N, Schimek-Jasch T, Kaier K, Duncker-Rohr V, Gkika E, Momm F, Gaertner J, Becker G, Grosu AL, Nestle U (2019) Early impact of pulmonary fractionated stereotactic body radiotherapy on quality of life:benefit for patients with low initial scores (STRIPE trial). J Thorac Oncol 14(3):408–419 Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37(18):1558–1565 Harrow S, Palma DA, Olson R, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Senthi S, Swaminath A, Kopek N, Liu M, Schlijper R, Bauman GS, Laba J, Qu XM, Warner A, Senan S (2022) Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes. Int J Radiat Oncol Biol Phys 114(4):611–616 Akanda ZZ, Neeson PJ, John T, Barnett S, Hanna GG, Miller A, Jennens R, Siva S (2021) A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer. Transl Lung Cancer Res 10(6):2766–2778 Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M (2016) Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases‑A pooled analysis of the German working group “stereotactic radiotherapy”. Lung Cancer 97:51–58 García-Mulero S, Alonso MH, Pardo J, Santos C, Sanjuan X, Salazar R, Moreno V, Piulats JM, Sanz-Pamplona R (2020) Lung metastases share common immune features regardless of primary tumor origin. J Immunother Cancer 8(1):e491 Oldenburg J, Berney DM, Bokemeyer C, Climent MA, Daugaard G, Gietema JA, De Giorgi U, Haugnes HS, Huddart RA, Leão R, Sohaib A, Gillessen S, Powles T, ESMO Guidelines Committee (2022) Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33(4):362–375 Rapoport BL, Shannon VR, Cooksley T, Johnson DB, Anderson L, Blidner AG, Tintinger GR, Anderson R (2021) Pulmonary toxicities associated with the use of immune checkpoint inhibitors: an update from the immuno-oncology subgroup of the neutropenia, infection & myelosuppression study group of the multinational association for supportive care in cancer. Front Pharmacol 12:743582 Haanen J, Obeid M, Spain L, Carbonnel F, Wang Y, Robert C, Lyon AR, Wick W, Kostine M, Peters S, Jordan K, Larkin J, Guidelines Committee ESMO (2022) Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. https://doi.org/10.1016/j.annonc.2022.10.001 Swain SM, Nishino M, Lancaster LH, Li BT, Nicholson AG, Bartholmai BJ, Naidoo J, Schumacher-Wulf E, Shitara K, Tsurutani J, Conte P, Kato T, Andre F, Powell CA (2022) Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. Cancer Treat Rev 106(102378):2022–2012. https://doi.org/10.1016/j.ctrv.2022.102378 Powell CA, Modi S, Iwata H, Takahashi S, Smit EF, Siena S, Chang DY, Macpherson E, Qin A, Singh J, Taitt C, Shire N, Camidge DR (2022) Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies. ESMO Open 7(4):100554